Company / Net Debt per Share
Vera Therapeutics, Inc. Net Debt per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$4.36
FY2025
5-year range
-$5.56 / $0.10
FY2021-FY2025
Trend
-474.6%
vs FY2024
Sector context
#75 of 82
Health Care
What the data says
Net Debt per Share changed -475% YoY in FY2025, a notable deviation from the 5-year average annual change of -210%.
Based on SEC 10-K filings.
-4.36 in FY2025.
Improved from $0.10 to $-4.36 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 82This company -$4.36 Sector average $13.70
▼
-131.8% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 474.6% year-over-year.
- Ranks #75 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2023.
- Lowest net debt per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.36 | -474.6% |
| FY2024 | -$0.76 | -871.9% |
| FY2023 | $0.10 | +114.0% |
| FY2022 | -$0.70 | +87.4% |
| FY2021 | -$5.56 | +96.7% |
| FY2020 | -$167.69 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026